Study guide

12.3 Ghana Expanded Programme on Immunization (EPI) & Pediatric Malnutrition

Nursing and Midwifery Council of Ghana Licensing Examinations Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: N&MC Ghana Regulation, Licensing Pathway & Examination Format

1.1 Health Professions Regulatory Bodies Act, 2013 (Act 857) & the N&MC Mandate 1.2 Cadres, Indexing, Eligibility, Examination Windows & Fees 1.3 Registration, PIN vs. AIN, Rotation, Licence Renewal & Foreign-Trained Pathway 1.4 Examination Format: Computer-Based Papers, Practical Component, Results & Re-sits

2 Chapter 2: Professional Ethics, Law, Leadership & Patient Rights

2.1 N&MC Ghana Code of Conduct, Ethical Principles & Professional Boundaries 2.2 Ghana Health Service Patients' Charter, Informed Consent & Confidentiality 2.3 Clinical Documentation, Incident Reporting, Negligence & Legal Liability 2.4 Nursing Leadership, Ward Management, Handover & Team Communication

3 Chapter 3: Infection Prevention, Control & Healthcare Safety

3.1 Standard & Transmission-Based Precautions, Hand Hygiene & PPE 3.2 Sterilization, Decontamination & Healthcare Waste Management in Ghana 3.3 Injection Safety, Sharps Injury Prevention & Occupational Post-Exposure Prophylaxis

4 Chapter 4: Clinical Nursing Foundations, Nursing Process & Practical Skills

4.1 Vital Signs Assessment, Clinical Deterioration & Early Warning Scoring 4.2 Medication Administration, Dosages, High-Alert Drugs & Pharmacovigilance 4.3 Enteral & Parenteral Nutrition, Fluid and Electrolyte Balance & Acid-Base Disorders 4.4 Pain Assessment, Analgesic Ladder & Palliative Care in Ghana 4.5 Nursing Process, Care Plans, Care Study & the Practical Examination

5 Chapter 5: Respiratory, Cardiovascular & Neurological Nursing

5.1 Airway, Breathing & Oxygen Therapy: Asthma, COPD & Pneumonia 5.2 Acute Coronary Syndromes, Heart Failure & Shock Classifications 5.3 Hypertension Management, Hypertensive Emergencies & Stroke Care 5.4 Neurological Nursing: Unconscious Patient, Head Injury, Raised ICP & Epilepsy

6 Chapter 6: Endocrine, Renal, Gastrointestinal & Liver Disorders

6.1 Diabetes Mellitus, DKA, HHS & Glycemic Emergencies 6.2 Acute Kidney Injury, Chronic Kidney Disease & Fluid Overload 6.3 Acute Abdomen, Peptic Ulcer Disease & Gastrointestinal Bleeding 6.4 Liver Disease (Hepatitis B, Cirrhosis, Hepatic Encephalopathy) & Thyroid Disorders

7 Chapter 7: Endemic Tropical Infections & Communicable Diseases

7.1 Malaria Management: Diagnostics, Uncomplicated & Severe Malaria Protocols 7.2 Tuberculosis Diagnosis, DOTS Protocol & Infection Control 7.3 HIV/AIDS Management, Antiretroviral Therapy (ART) & Opportunistic Infections 7.4 Enteric Infections: Cholera, Typhoid Fever & Diarrhoea Outbreak Response

8 Chapter 8: Hematology & Common Non-Communicable Conditions

8.1 Sickle Cell Disease: Vaso-Occlusive Crises, Anemia & Organ Protection 8.2 Blood Transfusion Practice, Crossmatching & Transfusion Reactions 8.3 Venous Thromboembolism, Anticoagulation & Pressure Injury Prevention

9 Chapter 9: Perioperative, Urological & Gynaecological Surgical Nursing

9.1 Preoperative Evaluation, Patient Preparation & Informed Consent 9.2 Intraoperative Care, Surgical Asepsis & WHO Surgical Safety Checklist 9.3 Postoperative Complications, Wound Healing & Dressing Techniques 9.4 Anesthesia Overview, Recovery Room (PACU) Care & Pain Management 9.5 Urological Surgical Nursing: Retention, BPH, Prostatectomy, Calculi & Catheter Care 9.6 Gynaecological Nursing: Ectopic Pregnancy, Abortion Care, Fibroids, PID & Cancer Screening

10 Chapter 10: Trauma, Burns & Acute Emergency Management

10.1 ABCDE Primary/Secondary Survey & Disaster Triage (START) 10.2 Major Burns: Rule of Nines, Parkland Fluid Resuscitation & Wound Care 10.3 Fractures, Immobilization, Compartment Syndrome & Spinal Precautions 10.4 Environmental Emergencies: Snakebites, Poisoning & Tetanus Prophylaxis

11 Chapter 11: Maternal Health, Obstetric & Postnatal Nursing

11.1 Antenatal Care (ANC/FANC), Risk Assessment & Health Promotion 11.2 Normal Labor, Stages & Partograph Monitoring 11.3 Obstetric Complications: Postpartum Hemorrhage (PPH) & Active Third Stage (AMTSL) 11.4 Hypertensive Disorders of Pregnancy: Preeclampsia, Eclampsia & MgSO4 11.5 Postnatal Care, Breastfeeding Support & Family Planning

12 Chapter 12: Neonatal & Pediatric Nursing Care

12.1 Immediate Newborn Care, APGAR Scoring & Neonatal Resuscitation 12.2 Integrated Management of Neonatal & Childhood Illness (IMNCI) 12.3 Ghana Expanded Programme on Immunization (EPI) & Pediatric Malnutrition

13 Chapter 13: Community Health Nursing & Primary Healthcare in Ghana

13.1 Community-Based Health Planning and Services (CHPS) Model 13.2 Disease Surveillance, Epidemic Preparedness & Community Health Education 13.3 Environmental Sanitation, Water Safety & School Health Services

14 Chapter 14: Mental Health Nursing & Psychiatric Care

14.1 Mental Health Act, 2012 (Act 846): Authority, Admission Routes & Rights 14.2 Common Psychiatric Disorders: Depression, Bipolar, Schizophrenia & Psychosis 14.3 Psychiatric Emergencies: Suicide Risk Assessment & De-escalation

12.3 Ghana Expanded Programme on Immunization (EPI) & Pediatric Malnutrition

Key Takeaways Explain This Topic AI

Ghana's EPI schedule gives BCG intradermally in the right upper arm, pentavalent vaccine IM in the left thigh, and PCV and IPV IM in the right thigh.

Ghana's schedule gives the malaria vaccine at 6, 7, 9 and 18 months, IM in the left thigh, in districts where it has been introduced.

Cold chain integrity mandates strict refrigerator storage between +2°C and +8°C, twice-daily temperature logging, interpretation of Vaccine Vial Monitors (discarding Stages 3 and 4), and the Shake Test for frozen adjuvanted vaccines.

Severe Acute Malnutrition (SAM) is defined by MUAC < 11.5 cm, WHZ < -3 SD, or bilateral pitting edema, presenting as non-edematous Marasmus (extreme wasting, senile facies) or edematous Kwashiorkor (bilateral pitting edema, moon facies, flaky paint dermatosis).

Inpatient SAM management strictly adheres to the WHO 10-Step protocol: Stabilization with F-75 milk, ReSoMal for dehydration, avoidance of standard IV fluids, avoidance of iron during acute stabilization, and transition to F-100 or RUTF only after edema resolves and appetite returns.

Last updated: September 2026

12.3 Ghana Expanded Programme on Immunization (EPI) & Pediatric Malnutrition

Quick Answer: Ghana's Expanded Programme on Immunization (EPI) schedule runs from birth (BCG, OPV0, hepatitis B birth dose) through 6, 10 and 14 weeks (pentavalent, OPV, PCV and rotavirus, plus IPV1 at 14 weeks), 7 months (IPV2), 9 months (measles-rubella 1, yellow fever) and 18 months (MR2, MenA), with the malaria vaccine at 6, 7, 9 and 18 months where introduced. The cold chain must maintain +2°C to +8°C for refrigerators, with freeze-sensitive vaccines evaluated via the Shake Test. Pediatric Severe Acute Malnutrition (SAM) is diagnosed via MUAC < 11.5 cm, WHZ < -3 SD, or bilateral pitting edema (Kwashiorkor). Inpatient SAM demands the WHO 10-step protocol: Stabilization using low-protein F-75 formula and ReSoMal (strictly avoiding standard IV fluids and iron), followed by Rehabilitation with F-100 or RUTF and delayed iron supplementation.

The Ghana National Expanded Programme on Immunization (EPI)

Established by the Ministry of Health and Ghana Health Service in accordance with WHO guidelines, the Expanded Programme on Immunization (EPI) is one of Ghana's most successful public health initiatives, drastically slashing mortality from measles, pertussis, neonatal tetanus, polio, and tuberculosis.

Complete National Immunization Schedule

Every nurse and midwife in Ghana must memorize the precise antigens, timings, dosages, routes, and anatomical injection sites of the national schedule:

  • Age / Contact Vaccine Target Disease Dose & Route Site (GHS schedule)
  • At birth BCG Tuberculosis (severe childhood forms) 0.05 mL intradermal Right upper arm
  • OPV0 Poliomyelitis 2 drops oral Mouth
  • Hepatitis B birth dose Hepatitis B 0.5 mL IM Anterolateral left thigh

6 weeks DPT-HepB-Hib 1 (Penta 1) Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus influenzae type b 0.5 mL IM Anterolateral left thigh

  • OPV1 Poliomyelitis 2 drops oral Mouth
  • PCV1 Pneumococcal disease 0.5 mL IM Anterolateral right thigh
  • Rota 1 Rotavirus diarrhoea 0.5 mL (5 drops) oral Mouth
  • 10 weeks Penta 2, OPV2, PCV2, Rota 2 As at 6 weeks As at 6 weeks As at 6 weeks
  • 14 weeks Penta 3, OPV3, PCV3, Rota 3 As at 6 weeks As at 6 weeks As at 6 weeks
  • IPV1 Poliomyelitis (inactivated vaccine) 0.5 mL IM Anterolateral right thigh
  • 6 months Vitamin A Vitamin A deficiency 100,000 IU oral Mouth
  • Malaria vaccine 1 Plasmodium falciparum malaria 0.5 mL IM Anterolateral left thigh
  • 7 months Malaria vaccine 2 Malaria 0.5 mL IM Anterolateral left thigh
  • IPV2 Poliomyelitis (inactivated vaccine) 0.5 mL IM Anterolateral right thigh
  • 9 months Measles-Rubella 1 Measles and rubella 0.5 mL subcutaneous Left upper arm
  • Yellow fever Yellow fever 0.5 mL subcutaneous Right upper arm
  • Malaria vaccine 3 Malaria 0.5 mL IM Anterolateral left thigh
  • 12 months Vitamin A Vitamin A deficiency 200,000 IU oral Mouth
  • 18 months Measles-Rubella 2 Measles and rubella 0.5 mL subcutaneous Left upper arm
  • MenA Meningococcal meningitis (serogroup A) 0.5 mL subcutaneous Left upper arm
  • Malaria vaccine 4 Malaria 0.5 mL IM Anterolateral left thigh
  • Vitamin A Vitamin A deficiency 200,000 IU oral Mouth
  • 24 months Vitamin A Vitamin A deficiency 200,000 IU oral Mouth
  • 9 years HPV Cervical cancer prevention 0.5 mL IM Right upper arm

Schedule notes (Ghana Health Service): after 18 months, vitamin A (200,000 IU) is given every 6 months until age 5; a long-lasting insecticidal net (LLIN) is given at 18 months; the malaria vaccine has had a phased introduction since 2019; HPV introduction was planned for 2025; Td for pregnant women follows a separate schedule (section 11.1); and missed doses follow the national catch-up policy.

The Ghana Malaria Vaccine Implementation Programme (MVIP)

Ghana was selected alongside Kenya and Malawi as pioneering rollout nations for the RTS,S/AS01 (Mosquirix) and newly approved R21/Matrix-M malaria vaccines. The vaccine is administered across implementing districts to prevent severe Plasmodium falciparum malaria and cerebral complications. The schedule consists of four primary doses :

  • Dose 1: 6 months of age;
  • Dose 2: 7 months of age;
  • Dose 3: 9 months of age (co-administered with Measles-Rubella 1 and Yellow Fever);

Dose 4: 18 months of age on the current GHS schedule (the pilot programme gave it at 24 months).

Vaccine Cold Chain Management and Safety

Vaccines are delicate biological substances that permanently lose potency when exposed to excessive heat, light, or freezing temperatures.

1. Temperature Regimes and Monitoring

Health Facility Refrigerator Compartment: Maintained strictly between +2°C and +8°C (optimum target: +4°C to +5°C );

Central / Regional Vaccine Store Freezers: Maintained between -15°C and -25°C (historically for bulk OPV storage and freezing water packs);

Temperature Logging: Temperature readings from calibrated thermometers or digital data loggers (Fridge-Tag) must be recorded twice daily (first thing in the morning and end of work day), 7 days a week , on the temperature chart affixed to the refrigerator door;

Refrigerator Storage Architecture:

Freeze-sensitive vaccines (Pentavalent, PCV, Td/TT, HepB, IPV) must be placed in the middle shelf , never touching the evaporator plates or bottom;

Heat-sensitive live viral vaccines (OPV, Measles-Rubella, BCG, Yellow Fever) are placed on the top shelf (below the freezer);

The bottom compartment/crisper contains bottles of water to maintain thermal inertia during power cuts;

The door shelves must NEVER hold vaccines (subject to severe temperature fluctuations during opening).

2. The Vaccine Vial Monitor (VVM)

The Vaccine Vial Monitor (VVM) is a heat-sensitive chemical indicator label affixed to the vaccine vial, reflecting cumulative heat exposure over time:

Principle: A light-colored square nested inside a darker circular reference ring. +-----------------------------------------------------------------------------------+

  • | VACCINE VIAL MONITOR (VVM) STAGES |
  • +---------+-------------------------------------------------+-----------------------+
  • | Stage | Visual Appearance of Inner Square vs. Circle | Decision / Action |
  • +---------+-------------------------------------------------+-----------------------+
  • | Stage 1 | Inner square is noticeably LIGHTER than circle. | USABLE: Vaccine safe |
  • | | No significant heat exposure. | to administer. |
  • +---------+-------------------------------------------------+-----------------------+
  • | Stage 2 | Inner square is still LIGHTER than circle. | USABLE: Use first if |
  • | | Mild heat exposure, but below threshold. | not expired. |
  • +---------+-------------------------------------------------+-----------------------+
  • | Stage 3 | Inner square MATCHES the color of the circle. | DO NOT USE: Discard |
  • | | Heat threshold reached! Potency lost. | immediately! |
  • +---------+-------------------------------------------------+-----------------------+
  • | Stage 4 | Inner square is DARKER than the circle. | DO NOT USE: Discard |
  • | | Severe heat exposure! Protein denatured. | immediately! |
  • +---------+-------------------------------------------------+-----------------------+
  • 3. Freeze Sensitivity and The Shake Test

Aluminum-adjuvanted vaccines ( Pentavalent, PCV, Td, Hepatitis B, and IPV ) lose their potency and form irreversible toxic aggregates when exposed to temperatures below 0°C . Freezing dissociates the antigen from the aluminum adjuvant, precipitating heavy granules.

To confirm whether a freeze-sensitive vaccine has been damaged by accidental freezing, the nurse performs The Shake Test :

Take a suspect vial and deliberately freeze a control vial of the exact same vaccine, lot, and manufacturer until solid, then allow it to thaw completely;

Vigorously shake both the suspect test vial and the thawed control vial simultaneously for 10–15 seconds;

Place both vials side by side on a flat surface against a clear light source and observe the sedimentation rate;

Interpretation:

If the suspect vial sediments slower than the frozen control, the test vaccine has NOT been frozen and is usable ;

If the suspect vial sediments at the same rate or faster than the frozen control (sediments rapidly within 15–30 minutes leaving a clear supernatant fluid), the suspect vaccine has been frozen and damaged. It MUST BE DISCARDED IMMEDIATELY .

Pediatric Severe Acute Malnutrition (SAM)

Malnutrition underlies more than one-third of all global child deaths, impairing cell-mediated immunity and transforming common childhood infections into fatal events.

Clinical Phenotypes: Marasmus vs. Kwashiorkor

Severe Acute Malnutrition (SAM) manifests as two distinct pathophysiological extremes:

Diagnostic Feature Marasmus (Severe Wasting) Kwashiorkor (Edematous Malnutrition)

Primary Etiology Severe caloric/energy starvation and overall nutrient deficit. Inadequate protein intake relative to carbohydrates (starchy weaning diets).

Hallmark Sign Severe muscle wasting and gross subcutaneous fat loss. Bilateral pitting edema starting in lower limbs.

Facial Appearance "Old man", "senile", or "wizened" monkey-like facies due to buccal fat pad loss. "Moon facies" (rounded, puffy cheeks from facial edema).

Skin Changes Dry, thin, loose skin folds ("baggy pants" around buttocks and thighs). "Flaky paint" dermatosis (crazy-paving hyperpigmentation, cracking, desquamation).

Hair Changes Usually normal texture and coloration. Sparse, thin, brittle, reddish/hypopigmented hair; "Flag sign" (alternating light/dark bands).

Abdomen & Liver Scaphoid or distended abdomen; liver is normal size. Hepatomegaly (enlarged liver due to massive hepatic steatosis / fatty infiltration).

Appetite & Mood Voracious / ravenous appetite; child is alert and hungry. Anorexia (poor appetite); extreme misery, apathy , and irritability.

Bilateral Edema Strictly absent. Always present (graded +, ++, or +++). Edema Grading in Kwashiorkor:

- Mild (+): Pitting edema restricted to both feet and ankles.

- Moderate (++): Edema extending to feet, lower legs, hands, or lower arms.

- Severe (+++): Generalized anasarca involving feet, legs, hands, arms, and facial edema (periorbital swelling).

Anthropometric Diagnostic Criteria for SAM (Age 6 to 59 Months)

A child aged 6 to 59 months is classified as having Severe Acute Malnutrition (SAM) if ANY ONE of the following criteria is met:

Mid-Upper Arm Circumference (MUAC): < 11.5 cm (115 mm) (indicated by the Red Zone on a standard tri-color insertion tape);

Weight-for-Height Z-score (WHZ): < -3 SD (Standard Deviations) on WHO Growth Standards;

Presence of Bilateral Pitting Edema: Regardless of weight-for-height or MUAC, bilateral pedal edema automatically defines the child as suffering from SAM.

WHO 10-Step Inpatient Management Protocol for SAM

Children with complicated SAM (poor appetite, severe edema +++, hypoglycemia, hypothermia, or systemic infection) have unstable metabolic reductive adaptation ("reductive adaptation" — suppressed sodium pumps, myocardial atrophy, impaired renal concentrating ability). They must be admitted for inpatient management following the WHO 10-Step Protocol . +-----------------------------------------------------------------------------------+

  • | WHO 10-STEP INPATIENT MANAGEMENT OF COMPLICATED SAM |
  • +----+------------------------------+-----------------------+-----------------------+
  • | Step / Intervention | Phase 1: Stabilization| Phase 2 / Phase 3 |
  • | | (Days 1 to 7) | (Days 8 to Discharge) |
  • +----+------------------------------+-----------------------+-----------------------+
  • | 1 | Treat / Prevent Hypoglycemia | Day 1–2 | |
  • | 2 | Treat / Prevent Hypothermia | Day 1–2 | |
  • | 3 | Treat / Prevent Dehydration | Day 1–2 (ReSoMal) | |
  • | 4 | Correct Electrolyte Imbalance| Days 1–7 | Throughout |
  • | 5 | Treat / Prevent Infections | Days 1–7 (Antibiotics)| |
  • | 6 | Correct Micronutrient Deficit| Days 1–7 (NO IRON!) | Add Iron in Phase 3! |
  • | 7 | Cautious Feeding | Days 1–7 (F-75 milk) | |
  • | 8 | Rebuild Wasted Tissue | | F-100 / RUTF |
  • | 9 | Provide Sensory Stimulation | | Play therapy |
  • | 10 | Prepare for Discharge | | Maternal education |
  • +----+------------------------------+-----------------------+-----------------------+
  • Detailed Analysis of Critical Steps
  • Steps 1 & 2: Hypoglycemia and Hypothermia

Hypoglycemia (blood glucose < 3.0 mmol/L or 54 mg/dL) and hypothermia (axillary temperature < 35.0°C) frequently coexist and cause sudden death;

Feed immediately upon admission. If hypoglycemic, administer 50 mL of 10% dextrose solution orally or via nasogastric tube (or 5 mL/kg IV 10% dextrose if unconscious);

Maintain room warmth (28°C–32°C), dress the child with a cap and socks, practice Kangaroo Mother Care, and feed every 2 hours day and night .

Step 3: Dehydration & The Critical Fluid Protocol

Diagnostic Challenge: Classic dehydration signs (sunken eyes, poor skin turgor) are present in marasmus solely due to subcutaneous fat loss. Over-diagnosing dehydration leads to fatal fluid overload;

Absolute Contraindication: NEVER USE STANDARD INTRAVENOUS FLUIDS (Normal Saline or Ringer's Lactate) for rehydration in SAM unless the child is in confirmed septic shock or hypovolemic shock. Malnourished children have sodium-overloaded cells, weak cardiac output, and reduced renal excretion; IV fluid boluses rapidly cause congestive heart failure and pulmonary edema;

ReSoMal (Rehydration Solution for Malnutrition): Oral rehydration MUST be conducted with ReSoMal , which is specifically formulated with lower sodium (45 mmol/L) , higher potassium (40 mmol/L) , and added magnesium, zinc, and copper ;

Administer ReSoMal orally or via nasogastric tube at 5 mL/kg every 30 minutes for the first 2 hours , then 5 to 10 mL/kg/hour over the next 4 to 10 hours.

Step 4: Correct Electrolyte Imbalance

All SAM children have deficient intracellular potassium and magnesium, despite high intracellular sodium. Administer extra potassium (3 to 4 mmol/kg/day) and magnesium (0.4 to 0.6 mmol/kg/day) added to therapeutic feeds for at least 2 weeks. Do NOT administer supplemental sodium.

Step 5: Treat Systemic Infections

Due to reductive adaptation, malnourished children cannot mount a fever or inflammatory leukocytosis. Severe occult bacterial sepsis is assumed in all inpatient SAM cases;

Administer broad-spectrum empirical antibiotics from Day 1:

Ampicillin (50 mg/kg IM/IV every 6 hours for 2 days), followed by oral Amoxicillin (15 mg/kg every 8 hours for 5 days);

PLUS Gentamicin (7.5 mg/kg IM/IV once daily for 7 days).

Step 6: Correct Micronutrient Deficiencies — The Iron Rule

Administer Vitamin A on Day 1 (50,000 IU for < 6m, 100,000 IU for 6–11m, 200,000 IU for >= 12m), unless documented within the past month;

Daily Folic Acid (5 mg on Day 1, then 1 mg daily), zinc, and copper;

CRITICAL CLINICAL RULE (NO IRON IN STABILIZATION): Never administer iron during Phase 1 (Stabilization). In severe malnutrition, transferrin levels are critically low. Administering iron results in unbound free iron that fuels virulent bacterial proliferation and catalyses free-radical membrane lipid peroxidation, dramatically increasing mortality. Iron is introduced ONLY during Phase 3 (Rehabilitation) , after the child develops a voracious appetite and has begun active catch-up growth (> 5 g/kg/day weight gain).

Steps 7 & 8: Therapeutic Diets (F-75 to F-100 / RUTF)

Phase 1 (Stabilization): Feed exclusively with F-75 therapeutic formula (75 kcal and 0.9 g protein per 100 mL). F-75 is low in protein, sodium, and osmolarity, designed to stabilize metabolic function without overloading the liver, kidneys, or myocardium. Feeds are given at 130 mL/kg/day (11 mL/kg every 2 hours);

Phase 2 (Transition): When bilateral edema is reduced and appetite returns, transition gradually over 2–3 days to F-100 formula (100 kcal and 2.9 g protein per 100 mL) or Ready-to-Use Therapeutic Food (RUTF / Plumpy'Nut) ;

Phase 3 (Rehabilitation): High-calorie catch-up growth (150 to 220 kcal/kg/day), weight gain monitoring (> 10 g/kg/day indicates excellent catch-up), play therapy, and maternal education.